As on Wednesday, Abeona Therapeutics Inc (NASDAQ: ABEO) got off with the flyer as it spiked 6.30% to $6.41, before settling in for the price of $6.03 at the close. Taking a more long-term approach, ABEO posted a 52-week range of $3.05-$9.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -15.07%. Meanwhile, its Annual Earning per share during the time was 38.92%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 35.11%. This publicly-traded company’s shares outstanding now amounts to $43.47 million, simultaneously with a float of $39.34 million. The organization now has a market capitalization sitting at $296.21 million. At the time of writing, stock’s 50-day Moving Average stood at $6.24, while the 200-day Moving Average is $5.76.
Abeona Therapeutics Inc (ABEO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Abeona Therapeutics Inc’s current insider ownership accounts for 9.50%, in contrast to 61.85% institutional ownership. According to the most recent insider trade that took place on Jun 18 ’24, this organization’s Director sold 25,890 shares at the rate of 4.51, making the entire transaction reach 116,764 in total value, affecting insider ownership by 36,926. Preceding that transaction, on Jun 18 ’24, Company’s Director sold 25,821 for 4.51, making the whole transaction’s value amount to 116,453. This particular insider is now the holder of 62,063 in total.
Abeona Therapeutics Inc (ABEO) Earnings and Revenue Records
Abeona Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 35.11% and is forecasted to reach -1.20 in the upcoming year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Let’s observe the current performance indicators for Abeona Therapeutics Inc (ABEO). It’s Quick Ratio in the last reported quarter now stands at 6.12. The Stock has managed to achieve an average true range (ATR) of 0.32.
In the same vein, ABEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.70, a figure that is expected to reach -0.34 in the next quarter, and analysts are predicting that it will be -1.20 at the market close of one year from today.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Through scrutinizing the latest numbers posted by the [Abeona Therapeutics Inc, ABEO], it can be observed that its last 5-days Average volume of 0.36 million was lower the volume of 0.43 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 63.28% While, its Average True Range was 0.32.
Raw Stochastic average of Abeona Therapeutics Inc (ABEO) in the period of the previous 100 days is set at 85.08%, which indicates a major rise in contrast to 68.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 40.88% that was lower than 47.67% volatility it exhibited in the past 100-days period.
